COVID-19 Vaccine Acceptance among Ajman Undergraduate Dental Students: A Cross-Sectional Study by M. A. Jaber, M. Abdelmagied, E. M. El-Ameen, K. I. Afrashtehfar

“…Achieving widespread coronavirus disease 2019 (COVID-19) vaccination is crucial in controlling the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This cross-sectional study aimed to identify factors associated with the willingness of dental medicine students to receive the COVID-19 vaccine. …”
Get full text

Risk Predictors for Mortality in Inpatients with Cancer and Coronavirus Disease 2019 during the Omicron Wave by Kuan-Yu Chen, Chih-Cheng Lai, Chien-Tai Huang, Yin-Hsun Feng

“…We analyzed the characteristics and risk factors for mortality in hospitalized patients with cancer and laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the Omicron wave. …”
Get full text

Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles by Grace Neilsen, Asha Maria Mathew, Jose M. Castro, William M. McFadden, Xin Wen, Yee T. Ong, Philip R. Tedbury, Shuiyun Lan, Stefan G. Sarafianos

“…ABSTRACT The coronavirus-induced disease 19 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections, has had a devastating impact on millions of lives globally, with severe mortality rates and catastrophic social implications. …”
Get full text

The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review by Roberto Debbag, Deborah Rudin, Francesca Ceddia, John Watkins

“…Beyond immediate disease prevention, immunization positively influences downstream health outcomes by mitigating complications of preexisting comorbidities and promoting healthy aging. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus, and respiratory syncytial virus (RSV) are common respiratory viruses responsible for broad societal cost and substantial morbidity and mortality, particularly among at-risk individuals, including older adults and people with frailty or certain comorbid conditions. …”
Get full text

Serum levels of the Parkinson's disease-linked protein Parkin are specifically elevated in COVID-19 by Nadezhda G. Gumanova, Natalya L. Bogdanova, Alexander Yu. Gorshkov

“…Background: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is known to cause various unfavorable effects, including neurodegenerative disorders. …”
Get full text

Application and mechanism of natural products and nutrient elements in COVID-19 by Lin Zhou, Yulin Tan, Lei Shi, Weibin Bai, Xiaoling Li

“…Coronavirus disease 2019 (COVID-19) is caused by the highly contagious virus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which has caused hundreds of thousands of deaths worldwide. …”
Get full text

Changes in some vascular biomarkers in patients with severe COVID-19 during prone positioning on various types of respiratory support by D. S. Shilin, A. V. Roslov, K. G. Shapovalov

“…INTRODUCTION. The severe acute respiratory syndrome-related coronavirus-2 (SARS-Cov2) virus is able to interfere with the interaction of angiotensin-converting enzyme with its receptor. …”
Get full text

An environmental study of tracheostomy on eight COVID-19 patients by Kai Xu, Xin-Hao Zhang, Xiao-Bo Long, Xiang Lu, Zheng Liu

“…Methods Samples obtained from the medical environment immediately after tracheostomy, including those from 19 surfaces, two air samples at 10 and 50 cm from the surgical site, and from the personal protective equipment (PPE) of the surgeon and assistant, were tested for the presence of severe acute respiratory syndrome coronavirus 2 in eight cases of bedside tracheostomy. …”
Get full text

Flavonoids Derived from the Roots of <i>Lespedeza bicolor</i> Inhibit the Activity of SARS-CoV Papain-like Protease by Hyun Sim Woo, Kon Ho Lee, Ki Hun Park, Dae Wook Kim

“…Despite the now infamous coronavirus disease outbreaks caused by severe acute respiratory syndrome coronavirus (SARS-CoV), this virus continues to be a threat to the global population. …”
Get full text

Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vi... by Nirmal Kumar, Irshad Maajid Taily, Charandeep Singh, Sahil Kumar, Raju S Rajmani, Debajyoti Chakraborty, Anshul Sharma, Priyanka Singh, Krishan Gopal Thakur, Raghavan Varadarajan, Rajesh P Ringe, Prabal Banerjee, Indranil Banerjee

“…Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus (IAV) poses enormous challenge in the development of broad-spectrum antivirals that are effective against the existing and emerging viral strains. …”
Get full text

Enhanced predictability and interpretability of COVID-19 severity based on SARS-CoV-2 genomic diversity: a comprehensive study encompassing four years of data by Miao Miao, Yonghong Ma, Jiao Tan, Renjuan Chen, Ke Men

“…Specifically, studying the impact of the genomic diversity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on COVID-19 severity is crucial for predicting severe outcomes. …”
Get full text

A review on phytogenic compounds inhibit coronaviruses associated with respiratory syndrome in human by Majid Gholami-Ahangaran, Maryam Karimi-Dehkordi

“…Materials and methods: PubMed databases were used to search for articles containing the terms coronavirus, SARS (Severe Acute Respiratory Syndrome), and MERS (Middle East Respiratory Syndrome), as well as human and herbal medicine. …”
Get full text

Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study by Rebecca A. G. Christensen, Shelby L. Sturrock, Jasleen Arneja, Jennifer D. Brooks

“…To assess if body mass index (BMI) and high waist circumference (HWC) are associated with testing positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods. 9,386 UK Biobank study participants tested for SARS-CoV-2 from March 16th 2020 to June 29th 2020 were analyzed. …”
Get full text

Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study. by Giovanni Manfredi Assanto , Matteo Totaro, Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile

“… Severe Acute Respiratory Syndrome CoronaVirus‐2 (SARS‐CoV‐2) infection can result in different clinical manifestations (COVID-19), starting from asymptomatic disease to life threatening respiratory insufficiency. …”
Get full text

Atomized Neutrophil Membrane-coated MOF Nanoparticles for Direct Delivery of Dexamethasone for Severe Pneumonia by Yixiao Yang, Lizhen Yan, Han Zhang, Chuanguang Xiao, Kai Wang

“…Background: Dexamethasone has proven life-saving in severe acute respiratory syndrome (SARS) and COVID-19 cases. However, its systemic administration is accompanied by serious side effects. …”
Get full text

Development and Evaluation of a Newcastle Disease Virus-like Particle Vaccine Expressing SARS-CoV-2 Spike Protein with Protease-Resistant and Stability-Enhanced Modifications by Yu Chen, Fan Tian, Shunlin Hu, Xiufan Liu

“…The ongoing global health crisis caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the continuous development of innovative vaccine strategies, especially in light of emerging viral variants that could undermine the effectiveness of existing vaccines. …”
Get full text

Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19 by George G. Zhanel, Michael A. Zhanel, Kevin F. Boreskie, Joseph P. Lynch, James A. Karlowsky

“…Preliminary data indicated that HCQ as well as chloroquine (CQ) possessed in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early clinical data from China and France reported that HCQ and CQ were associated with viral load reduction and clinical improvement in patients with COVID-19 compared to control groups; however, an overwhelming number of randomized controlled trials, meta-analyses, and systematic reviews have since concluded that HCQ used alone, or in combination with azithromycin (AZ), provides no mortality or time-to-recovery benefit in hospitalized patients with COVID-19. …”
Get full text

An Insight into the Pathogenesis, Diagnosis and Treatment of SARS-Cov-2 with a Synopsis of Situation in Malaysia during the 2020 Outbreak by Zaidah Abdul Rahman, Yusuf Wada, Musa S. Kaware, Suwaiba Muhammad Ladan

“… Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the novel coronavirus (CoV) that emerged from China causing diseases known as COVID-19, mainly involves the respiratory system. …”
Get full text

COVID-19 vaccination: challenges in the pediatric population by Alice Nicoleta Azoicai, Ingrith Miron, Ancuta Lupu, Monica Mihaela Alexoae, Iuliana Magdalena Starcea, Mirabela Alecsa, Vasile Valeriu Lupu, Ciprian Danielescu, Alin Horatiu Nedelcu, Delia Lidia Salaru, Felicia Dragan, Ileana Ioniuc

“…The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affected people of all ages worldwide. …”
Get full text

Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment by Charles Reynard, James Campling, Adam L Gordon, George Kassianos, Hui-Hsuan Liu, Alex Richter, Andrew Vyse, Dexter J Wiseman, Hannah Wright, Gillian Ellsbury

“…Introduction Vaccine-preventable respiratory infections (VPRI) including those caused by Streptococcus pneumoniae, influenza, respiratory syncytial virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pose substantial challenges to health and social care systems. …”
Get full text